Dimensional Fund Advisors
TMCI icon

Dimensional Fund Advisors’s Treace Medical Concepts TMCI Stock Holding History

Dimensional Fund Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625K Sell
156,748
-37,748
-19% -$104K ﹤0.01% 2941
2026
Q1 		$260K Sell
194,496
-78,880
-29% -$157K ﹤0.01% 3034
2025
Q4 		$670K Buy
273,376
+28,912
+12% +$126K ﹤0.01% 2926
2025
Q3 		$1.64M Buy
244,464
+22,867
+10% +$149K ﹤0.01% 2812
2025
Q2 		$1.3M Buy
221,597
+149,955
+209% +$977K ﹤0.01% 2847
2025
Q1 		$601K Hold
71,642
– – ﹤0.01% 2974
2024
Q4 		$533K Sell
71,642
-101
-0.1% -$676 ﹤0.01% 3025
2024
Q3 		$416K Hold
71,743
– – ﹤0.01% 3068
2024
Q2 		$477K Sell
71,743
-13,197
-16% -$107K ﹤0.01% 3034
2024
Q1 		$1.11M Sell
84,940
-2,084
-2% -$27.8K ﹤0.01% 2907
2023
Q4 		$1.11M Sell
87,024
-189,099
-68% -$1.91M ﹤0.01% 2913
2023
Q3 		$3.62M Buy
276,123
+200,654
+266% +$3.67M ﹤0.01% 2627
2023
Q2 		$1.93M Buy
+75,469
New +$1.95M ﹤0.01% 2793

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors's TMCI Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Treace Medical Concepts (TMCI) stake by 19% in Q2 2026, selling an estimated $104K and leaving 156,748 shares worth $625K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

Dimensional Fund Advisors first reported a position in TMCI in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.62M in Q3 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Dimensional Fund Advisors held 156,748 shares of Treace Medical Concepts worth $625K as of Q2 2026.
  • Dimensional Fund Advisors sold 37,748 Treace Medical Concepts shares in Q2 2026, an estimated $104K.
  • Treace Medical Concepts made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2941 holding.
  • Dimensional Fund Advisors first reported a position in Treace Medical Concepts in Q2 2023 and has held it in 13 quarters since.
  • Dimensional Fund Advisors's Treace Medical Concepts position peaked at $3.62M in Q3 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.